Back to Search
ALFRED SANDROCK, MD PHD
MD PHD
Neurology Physician
NPI: 1740261965Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
72479(MA)
Research & Publications (20)
Assessing disability progression with the Multiple Sclerosis Functional Composite.
PMID 19667023·Mult Scler·2009
8-other
Proof of concept studies for tissue-protective agents in multiple sclerosis.
PMID 19389749·Mult Scler·2009
6-review
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
PMID 19255407·Neurology·2009
3-trial
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
PMID 18970976·Lancet·2008
3-trial
LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence.
PMID 18774923·Expert Opin Biol Ther·2008
6-review
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.
PMID 17452584·Neurology·2007
3-trial
Infusion-related hypersensitivity reactions during natalizumab treatment.
PMID 17101921·Neurology·2006
5-case
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
PMID 16510745·N Engl J Med·2006
3-trial
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
PMID 16510744·N Engl J Med·2006
3-trial
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients.
PMID 16323317·Mult Scler·2005
3-trial
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study.
PMID 16009883·Neurology·2005
2-rct
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
PMID 15853576·Expert Rev Neurother·2004
6-review
The blood-brain barrier as target of multiple sclerosis research and therapy. Report of an international scientific meeting, Würzburg, January 23/24, 2004.
PMID 15303274·J Neuroimmunol·2004
7-preclinical
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.
PMID 14638957·Neurology·2003
8-other
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS.
PMID 12451189·Neurology·2002
3-trial
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
PMID 12221157·Neurology·2002
3-trial
Noninvasive detection of fibrillation potentials in skeletal muscle.
PMID 12148817·IEEE Trans Biomed Eng·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15 PARKMAN ST, NEUROLOGY ASSOCIATES WAC 835
BOSTON, MA 02114 - Phone
- (617) 724-3914
Quick Facts
- NPI
- 1740261965
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile